Skip to main content
OpenTrials

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

NCT06988618

Conditions
Prurigo Nodularis
Locations
  • Galderma Investigational Site # 8893 Birmingham, Alabama, United States
  • Galderma Investigational Site # 7077 Phoenix, Arizona, United States
  • Galderma Investigational Site # 7060 Phoenix, Arizona, United States
  • Galderma Investigational Site # 7067 Tucson, Arizona, United States
View all 51 locations
View Trial Details
Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

NCT06293053

Conditions
Prurigo Nodularis
Locations
  • Stanford University Medical Center CTRU - 800 Welch Road- Site Number : 8400021 Palo Alto, California, United States
  • Mission Dermatology Center- Site Number : 8400011 Rancho Santa Margarita, California, United States
  • Pediatric Center of Excellence (PCE) - Miami Pediatric Endocrinology- Site Number : 8400005 Coral Gables, Florida, United States
  • Life Clinical Trials - Coral Springs- Site Number : 8400018 Coral Springs, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

NCT06087627

Conditions
Prurigo Nodularis
Locations
  • Investigational Site Number: 013 Adernach, Germany
  • Investigational site number: 001 Berlin, Germany
  • Investigational Site Number: 002 Berlin, Germany
  • Investigational Site Number: 023 Chemnitz, Germany
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

NCT06516952

Conditions
Prurigo Nodularis
Locations
  • Cahaba Dermatology Birmingham, Alabama, United States
  • Banner - University Medicine Multispecialty Services Clinic Tucson, Arizona, United States
  • Premier Dermatology Clinical Trials Institute At Northwest Arkansas Fayetteville, Arkansas, United States
  • Burke Pharmaceutical Research Hot Springs, Arkansas, United States
View all 120 locations
View Trial Details

Related conditions